Background: Preoperative biliary drainage is often initiated with endoscopic biliary drainage (EBD) in
INTRODUCTION
Perihilar cholangiocarcinoma (PHC) is the most common type of cholangiocarcinoma with a median overall survival of 12 months if locally advanced or metastatic at presentation. 1 A combined extrahepatic bile duct and liver resection for resectable tumors has a median overall survival of 30-40 months in large series. [2] [3] [4] Unfortunately, surgical resection has been associated with a high rate of postoperative mortality (3%-18%). [2] [3] [4] [5] [6] [7] [8] [9] Liver failure is the most common cause of postoperative death and has been attributed to extended liver resections in the setting of biliary obstruction and cholangitis. 10, 11 Biliary drainage of the future liver remnant (FLR) is recommended by some to resolve biliary obstruction and improve liver function preoperatively. 12 Adequate drainage of the FLR, as reflected by normalized total bilirubin level and normal caliber biliary ducts, can potentially decrease postoperative morbidity, provided that the FLR volume is adequate. Two methods are used for biliary drainage: endoscopic biliary drainage (EBD) and percutaneous transhepatic biliary drainage (PTBD).
The majority of patients referred to specialty centers for surgical treatment have already undergone (attempted) endoscopic drainage before referral. 13 However, EBD for proximal biliary obstruction may not always offer adequate biliary drainage and may contaminate undrained segments. 13, 14 Many patients require additional PTBD to obtain adequate preoperative biliary drainage or to treat infectious complications related to failed endoscopic stents. PTBD has the advantage of offering selective drainage of the FLR and can be useful in treating cholangitis with multiple isolated segments. In a previous report, out of 90 patients in whom biliary drainage for potentially resectable PHC was initiated with EBD, 30 patients (33%) required additional preoperative PTBD. 13 Patients who have a high risk for additional preoperative PTBD after inadequate initial EBD may benefit from PTBD as the initial treatment. These patients could avoid the risks associated with EBD, including acute pancreatitis and contamination of undrained liver segments. The aim of this study was to develop and validate a prediction model to identify patients with a high risk of requiring additional preoperative PTBD after initial EBD.
METHODS

Patients
Consecutive patients who underwent exploratory laparotomy with curative intent for presumed PHC between January 2001 and December 2013 were identified from prospectively maintained databases at two institutions: the Academic Medical Center (AMC) in Amsterdam, The Netherlands, and Memorial Sloan Kettering Cancer Center (MSKCC) in New York, USA. Criteria used in both centers to select patients for exploratory laparotomy and potential resection are detailed in Table 1 .
The institutional review board at both institutions approved this study; at MSKCC, compliance with the Health Insurance Portability and Accountability Act (HIPAA) was ensured.
CHAPTER 1
All included patients had an obstruction of the common hepatic duct, with or without obstruction of the bifurcation and second-order bile ducts, that was suspicious for PHC. Patients with obstruction of the left or right hepatic duct alone, without obstruction of the bifurcation, were not included in this study because these tumors normally do not cause jaundice and have no indication for preoperative stenting. All patients who underwent (attempted) EBD with plastic stent placement as the initial biliary drainage procedure were included.
Exclusion criteria were: no (attempted) preoperative drainage, endoscopic metal stents, 15, 16 and a history of benign bile duct obstruction or cholecystitis with drainage procedures prior to suspicion of PHC. Patients who underwent PTBD as the initial drainage method were not included in the study cohort but were separately analyzed. 
Preoperative biliary drainage
Adequate preoperative biliary drainage requires decompression of the bile ducts in the FLR and a total bilirubin level below 50 µmol/L (2.9 mg/dL). Therefore, the left liver segments need to be drained in patients scheduled for right hepatectomy, and the right liver segments need to be drained in patients scheduled for left hepatectomy.
An attempt at EBD was initiated either in a regional center before referral or in one of the two specialty centers after referral. The initial EBD procedure, if technically successful, most often resulted in placement of a single 10-Fr stent. At presentation in the specialty centers, all patients with a suspicion of PHC were staged with computed tomography (CT) and/or magnetic resonance imaging (MRI) and evaluated in a multidisciplinary team meeting. 17 Preoperative biliary drainage or additional biliary drainage was considered if cholestasis was present in the FLR as evidenced by elevated total bilirubin level and/or dilated bile ducts in the FLR, or if there were signs of cholangitis not responding to antibiotic treatment. When additional drainage was indicated, at AMC, the optimal method (repeat EBD or PTBD) for the additional drainage procedure 1 was selected during a multidisciplinary team meeting, based on the cause of drainage failure and the biliary anatomy. 16 In some patients, repeat EBD was used to obtain adequate drainage and PTBD was not required. In others, repeat EBD was not considered technically feasible and additional PTBD was used. At MSKCC, PTBD was used in all patients who required additional biliary drainage before exploratory laparotomy. At both centers the decision to proceed with additional PTBD was ultimately at the discretion of the attending surgeon. The techniques of EBD and PTBD have been described previously.
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Definitions
The endpoint in the prediction model was the indication for additional PTBD after initial (attempted)
EBD. Indications for additional PTBD were classified as one of the following: technical failure of EBD, defined as the inability to insert a draining stent; therapeutic failure of endoscopic stents, defined as persistent jaundice or recurrent jaundice prior to surgery; cholangitis after EBD not responding to antibiotic treatment, characterized by fever, leukocytosis and raised total bilirubin; insufficient drainage of the FLR, characterized by persistent dilatation of the FLR bile ducts. The latter indication occurred when an endoscopic stent was placed in the contralateral bile ducts and relieved jaundice without draining the bile ducts in the FLR, so that the increased risk of postoperative liver failure from obstruction in the FLR was maintained despite a normalized bilirubin level. 6 Study variables were restricted to data that were available before biliary drainage was initiated. These variables included demographics, comorbidities (Charlson comorbidity score), 18 the type of hospital where the initial procedure was performed (specialty versus regional center), predrainage total bilirubin level, and proximal extent of bile duct obstruction on imaging according to the Bismuth criteria. 19, 20 The available preoperative images were retrospectively reviewed when the level of bile duct obstruction was missing in the original radiology reports (by C.Y.N. at AMC and by B.G.K. in MSKCC).
Statistical analysis
For the study variable predrainage total bilirubin level, 11% of values (n = 17) were missing in the AMC cohort and 19% (n = 25) in the MSKCC cohort. These values were missing when the referral center had not included laboratory values in the referral letter and were therefore considered to be missing at random. Missing predrainage total bilirubin values were imputed with multiple imputation in both the derivation and validation cohort (five imputation cohorts). 21 A regression model was used with all study variables as well as with the available preoperative bilirubin levels. The data was pooled using Rubin's rule. 22 Univariable and multivariable analyses were performed on the AMC cohort, which led to the development of a prediction model. Study variables were dichotomized around a cut-off, as determined by optimal sensitivity and specificity in the derivation dataset, 23 to allow clinical interpretation. In univariable analysis, associations were analyzed using Fisher's exact test, Pearson chi-squared test, or Mann-Whitney U test, as applicable. All study variables were entered into a multivariable logistic regression model and were evaluated using automated conditional backward selection with a cut-off value of P = 0.1 to be retained in the regression model. Risk groups that were identified by the multivariable analysis were then collapsed into three groups (i.e. high, moderate, and low risk) using nearest neighbor clustering. 24 Logistic regression with the new grouping variable as a single predictor was used to determine the corresponding predicted outcomes. The resultant prediction model is presented as a table with predictions. This model was subsequently validated in the external MSKCC cohort. We assessed the prediction model in terms of discrimination (area under the curve [AUC]) and calibration. 25 Subsequently, the total number of drainage procedures was analyzed in patients who underwent PTBD, with and without previous EBD, using univariable analysis as described above. This comparison aimed to assess the potential gain if patients had been treated with initial PTBD instead of initial EBD, as proposed in the prediction model. All analyses were performed in SPSS v22 (SPSS Inc., Chicago, Illinois, USA), and R (a language and environment for statistical computing), version 3.0.2.
RESULTS
Study cohort
There were 405 patients who underwent exploratory laparotomy with curative intent for presumed PHC identified from the two databases. Patients without preoperative biliary drainage (n = 51) were excluded, and patients who underwent initial PTBD (n = 45) were analyzed separately. Preoperative biliary drainage was initiated with (attempted) EBD in the other 309 patients (76%). An additional 21
patients were excluded, including 11 because of metal stent placement, resulting in 288 patients for the final study cohort (158 from AMC in the derivation cohort and 130 from MSKCC in the validation cohort). Figure 1 details the inclusions and exclusions in a flowchart.
In the study cohort, the final pathology after surgery confirmed the diagnosis of PHC in 273 of the 288 patients (95%) and showed that 15 patients (5%) had benign disease. Among patients with PHC, 122 (45%) underwent bile duct resection combined with a liver resection and 25 (9%) underwent a bile duct resection only; 126 patients (46%) underwent no resection because of an intraoperative diagnosis of locally advanced or distant metastatic disease.
Postoperative 90-day mortality after resection of PHC was 14% (21/147 patients) and median overall survival after resection of PHC was 37 months (95% confidence interval [CI] 25-49 months).
Preoperative biliary drainage procedures
The median number of preoperative EBD procedures in the prediction model cohort was one (range 1-5), although 121 patients (42%) underwent two or more EBD procedures. EBD was adequate in 180 patients (62.5%), but ultimately 108 of the 288 patients (37.5%) required additional PTBD after the initial EBD. Therapeutic failure of endoscopic stents was the most common indication for additional PTBD (n = 42; 15%), followed by cholangitis after EBD (n = 31; 11%), technical failure of endoscopic stenting (n = 18; 6%), and insufficient drainage of the FLR (n = 17; 6%). A single PTBD 1 procedure was sufficient in 35 of these patients (32%), but the median number of additional PTBD procedures was two (range 1-6), and 35 patients (32%) required three or more PTBD procedures.
Patient characteristics and biliary drainage details from the two separate cohorts (AMC and MSKCC) are presented in Table 2 . The indications for additional PTBD in each center are shown in Table 3 .
Multivariable analysis
Demographics, comorbidities, and the hospital type for the initial EBD procedure (specialty versus regional referral center) were not associated with the indication for additional PTBD after initial EBD.
The predrainage bilirubin level showed predictive value, after determining a cut-off of 150 µmol/L (sensitivity 0.69, 95%CI 0.56-0.80; specificity 0.55, 95%CI 0.44-0.66).
Multivariable analysis in the AMC cohort showed that a predrainage total bilirubin level above 150 µmol/L (8.8 mg/dL) and the proximal extent of bile duct obstruction were independent predictors ( Table 4) . Eight risk groups (2 × 4) were identified based on these predictors.
Model derivation
The eight risk groups were collapsed into three risk groups based on the observed incidence of additional PTBD in the AMC cohort (Figure 2) . The low-risk group (n = 29) consisted of patients without second-order bile duct obstruction (Bismuth 1 or 2) . The moderate-risk group (n = 77) consisted of patients with left-sided second-order bile duct obstruction (Bismuth 3b) regardless of the predrainage total bilirubin level, and patients with right-sided or bilateral second-order bile 40% for the moderate-risk group, and 62% for the high-risk group. Table 3 . Indications for additional percutaneous transhepatic biliary drainage (PTBD) in the patient cohorts at the two study centers.
AMC (n = 158) MSKCC (n = 130)
Number of patients requiring additional PTBD, n (%) 65 (41%) 43 (33%)
Indication for additional procedure, n (%) 
Model validation
The prediction model showed good discrimination in the AMC derivation cohort (AUC 0.72; 95%CI 0.63-0.80), as well as in the MSKCC validation cohort (AUC 0.74; 95%CI 0.64-0.83). Table 5 shows adequate calibration of the prediction model. Patients in the high-risk group required additional preoperative PTBD in 62% of patients in the MSKCC validation cohort, which was identical to the predicted risk. 
Patients with initial PTBD
The number of drainage procedures was compared between the group of 108 patients who underwent additional PTBD after inadequate EBD and the group of 45 patients who underwent initial PTBD without previous EBD. Both groups were comparable in terms of the predictive factors identified in this study, as shown in Table 6 .
1 Table 6 . Number of drainage procedures in patients who underwent additional percutaneous transhepatic catheter biliary drainage (PTBD) after initial endoscopic biliary drainage (EBD) drainage and in patients who underwent initial PTBD. The median number of preoperative drainage procedures was significantly lower in those patients who were initially treated by PTBD compared with those initially treated by EBD (two versus four, respectively; P < 0.001).
Variable
DISCUSSION
Preoperative biliary drainage potentially creates a safer environment in jaundiced patients prior to liver surgery for PHC; it improves function and regeneration in the FLR. 12 The decision to use drainage and the method of drainage chosen should be tailored to the anticipated resection following careful examination of CT and/or MRI images. 16 Not all patients benefit from preoperative drainage, for example patients scheduled for pancreatectomy or local bile duct resection will not benefit, 26 but it has been shown to reduce perioperative morbidity in patients selected to undergo large liver resections for PHC. 6, 7 This study set out to predict inadequate preoperative EBD requiring additional PTBD in patients with potentially resectable PHC. Two predictors were identified: the proximal extent of bile duct obstruction and the predrainage total bilirubin level. These factors were used to design a prediction model with three risk groups that was derived from the AMC cohort in Europe. The risk groups A median of four preoperative drainage procedures was observed in patients who required additional PTBD after inadequate EBD. In comparison, we analyzed the number of drainage procedures in a comparable group of 45 patients who underwent initial PTBD without previous EBD and showed that these patients underwent significantly fewer drainage procedures. Reducing the number of preoperative biliary drainage procedures in patients with PHC is important because every biliary drainage procedure has associated procedural risks, such as acute pancreatitis, and may cause patient discomfort. 13 Moreover, biliary drainage and, in particular, inadequate biliary drainage can cause cholangitis, which is the most important risk factor for postoperative mortality after major liver resections for PHC.
5,11
The total bilirubin level reflects the extent and severity of obstruction in the bile ducts, so a raised level may reflect a stricture that is difficult to drain endoscopically. The level of bile duct involvement predicts the need for additional preoperative PTBD for several reasons. EBD is less technically demanding and has good outcome in patients with Bismuth 1 or 2 tumors, as previously shown by others. 27 Tumors with obstruction of second-order bile ducts (i.e. ≥Bismuth 3) are more difficult to manage endoscopically, but the anatomical relation between the tumor and the bile ducts is critical within this group. The left liver segments are more difficult to drain endoscopically than the right because the angle of the left hepatic duct is sharper and more difficult to negotiate with the endoscopic guidewire. Therefore, preoperative PTBD is more often required in patients with type 3a or 4 tumors, who more often require right (extended) hepatectomy and preoperative drainage of the left liver segments, compared with patients with type 3b tumors, who require left hepatectomy and preoperative drainage of the right liver segments. In addition, Bismuth 3a and 4 tumors cause isolation of two large sections of the liver, the right anterior and posterior sections, representing about two-thirds of the liver volume. 28 Therapeutic failure after EBD is common in these patients because a single stent only drains about a third of the liver, and there is a higher risk of contaminating obstructed biliary radicles and cholangitis. Corroboratively, type 3a and 4 tumors had the highest odds ratios for requiring additional PTBD in the statistical model and were consequently grouped together as "high risk" by the automated clustering.
Endoscopic guidelines, including the European Society of Gastrointestinal Endoscopy (ESGE) guideline published in this journal, recommend that endoscopic drainage of perihilar strictures should be performed in high-volume centers. 15, 16 Although the hospital type for the initial 1 EBD procedure (regional versus specialty center) was not associated with failure or success of preoperative endoscopic biliary drainage in this study, it seems preferable to refer patients at an early stage. Multidisciplinary teams in specialty centers have wide experience in assessing resectability, evaluating the indication for biliary drainage, and choosing the optimal method of biliary drainage to be used. Moreover, both EBD and PTBD methods are readily available in most Western high-volume centers, whereas only few regional centers have the necessary expertise for PTBD.
There are a number of strengths to this study. Although it has previously been shown that PTBD is a better option than EBD for palliative drainage of Bismuth 3 and 4 tumors, this is the first study providing a clinical decision rule for preoperative drainage in patients with potentially resectable PHC. Furthermore, the study setup, which focused on patients with EBD stents, reflects current practice because most patients are currently being referred to specialty centers with an EBD stent in situ. Many of these patients (38% in the present study) have inadequate drainage after EBD so could have benefited from initial PTBD.
Derivation of the prediction model in a European center and subsequent validation in a US center also showed that the predictions are robust and surpass cultural differences in drainage policy that may exist between centers. Finally, this is the largest reported series of patients with biliary drainage for PHC (n = 288), while it consists solely of patients who were selected for surgical therapy.
There are several limitations to this retrospective study. The cohorts included patients who underwent drainage in regional or specialty centers in two different continents, so some heterogeneity in procedural methods can be expected. Consequently, the results of this study may not translate to specialized endoscopists with vast experience in drainage of PHC. Secondly, as the model was optimized for prediction, care must be taken when interpreting the presented odds ratios for etiologic risk factors, as they were not adjusted for all potential confounders.
Thirdly, selection of predictors in the model was based on backward regression, even though more sophisticated methods, such as model selection with the least absolute shrinkage and selection operator (LASSO), have recently been developed. 29 Nonetheless, discrimination and calibration were both good in the external validation dataset, which we took as evidence that the derived prediction model was accurate. Fourthly, we used multiple imputation of the missing predrainage total bilirubin levels in both the derivation and validation cohort. 21 Although imputation may have introduced a small bias, imputation of missing variables has been shown to decrease the risk of bias by not excluding patients with missing values. 30 Fifthly, this study included 288 patients who underwent exploratory laparotomy after initial endoscopic drainage, but the intended resection was not performed in a large subset of patients (46%) because of an intraoperative diagnosis of locally advanced or distant metastatic disease.
Unfortunately, a finding of inoperability at the time of surgery is common among patients with PHC, and improvements in preoperative staging are much needed for better patient selection.
CHAPTER 1
Lastly, this study could not evaluate whether PTBD is associated with a lower rate of complications or better oncologic outcome than EBD. Opinions on the preferred method of preoperative biliary drainage vary greatly, all based on retrospective data. EBD is widely available and is considered to be less invasive than a PTBD. Japanese institutions advocate EBD and, in particular, endoscopic nasobiliary drainage because PTBD tract metastases have been described in 2%-5% after preoperative PTBD and resection of PHC. [31] [32] [33] Other centers prefer to use preoperative PTBD.
Percutaneous drainage has the ability to selectively drain liver segments, and percutaneous drains may reduce hepaticojejunostomy leaks postoperatively. Moreover, preoperative PTBD has been associated with lower rates of cholangitis in small series; 13,14 a clinical trial is currently being conducted to assess such differences. 34 In conclusion, we derived and validated a prediction model that identifies patients with potentially resectable PHC who are likely to require preoperative PTBD after inadequate drainage with EBD alone. Patients with obstruction of the right-sided or bilateral second-order bile ducts (Bismuth 3a or 4) and a total bilirubin level above 150 µmol/L (8.8 mg/dL) have a high risk (62%) of requiring additional preoperative PTBD after initial EBD. These patients should therefore be considered for initial PTBD rather than endoscopic drainage to minimize the total number of drainage procedures.
